1- Armitage JO, Longo DL. Malignancies of lymphoid cells. In: Kasper DL. Harrison’s principles of internal medicine.
17th ed. New York: Mc Graw- Hill; 200.p. 641- 650.
2- Iochim H, Ratech H. Hodgkin lymphoma. In: Iochim H, Ratech H.Lymph Node Pathology. 4thed. New York:
Lippincott Williams & wilkins; 2009.p.327- 348.
3- Fraga M, Sanchez L, Forteza, Forteza J, García-Rivero A, Piris MA. T cell rich B cell lymphoma is a disseminated
aggressive neoplasm differential diagnosis from Hodgkin’s lymphoma. Histopathology 2002; 41:216- 29.
4- Karimi M, Yarmohammadi H, Ghavanini AA, Kumar PV. Epidemiological surveillance of pediatric Hodgkin’s
disease in southern Iran. Med Sci Monit 2002; 8:572-575.
5- Almars NM. Hodgkin’s lymphoma in North Jordan. Saudi Med J 2004; 25:1917-1921.
6- Rosai J. lymph node. In: Rosai J. Rosai and Ackerman’s surgical pathology.9 th ed. New York: Mosby; 2004.p.1917-
1930.
7- Pileri SA, Ascani S, Leoncinil L,Sabattini E, Zinzani PL,Piccaluga PP, et al. Hodgkin’s lymphoma the pathologist
viewpoint. J Clin Pathol 2002; 55:162-176.
8- Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European American Classification of
lymphoid neoplasm. Blood 1994; 84:1361-1392.
9- Schnitzer B. Hodgkin Lymphoma . Hematol Oncol Clin North Am 2009; 23:747-768.
10- Chan J. Tumors of the lymphoreticular system. In: Diagnotic histopathology of tumors. 2 th ed. London: Churchill
Livigstone; 2000. p. 112- 128.
11- Kadin M. Hodgkin’s lymphoma. In: Dabbs D. Diagnostic Immunohistochemistby:diagnostic, theranostic and
genomic applications .3rd ed. Philadelphia: Saunders – Elsevier ; 2009.p.135- 145.
12- Listinsky CM. A practical approach to diagnosis to the diagnosis of Hodgkin lymphoma. Am J Clin Pathol 2002;
117:76- 94.
13- Charafe E. Characterization of Hodgkin’s lymphoma like undifferentiated carcinoma of the nasopharynged type as
a particular UCNT Subtype mimicking Hodgkin’s lymphoma .J Oncol 2003; 23:97- 103.
14- Liu Y, Zhung H, Liao X. Immunophenotype and differential diagnosis of Hodgkin’s lymphoma . Zhonghua Xue Ye
Xue Za Zhi 2002; 23:524-527.
15- Kansal R, singleton TP, Ross CW, Finn WG, Padmore RF, Schnitzer B.. Follicular Hodgkin lymphoma. Am J Clin
Pathol 2002; 117:29- 35.
16- Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin
and Hodgkin lymphoma. Arch Pathol Lab Med 2008; 132:441-461.
17-Gazal D,Andre H,Mounier N. Pathologic and clinical features of 77 Hodgkin’s lymphoma patients treated in a
lymphoma protocol. Am J Surg Pathol 2001; 25:297-306.
18- Iraj Ak . Hodgkin’s disease: assessment of treatment and survival rates in Iran. Asian Pac Cancer Prev 2004; 5:379-
382.
19- Jose BO, Koerner P, Spanos WJ, Paris KJ, Silverman CL, Yashar C, et al. Hodgkin’s lymphoma in adult. J ky Med
Assoc 2005; 103:15-7.
20- Boudova L, Torlakovic E. Nodular lymphocyte predomimant Hodgkin l ymphoma with nodular resembling T cell
rich B cell lymphoma: differential diagnosis. Blood 2003; 102:3753-3756.
21- Rudiger T, Ott G, Ott MM. Diffrential diagnosis between classic Hodgkin’s lymphoma , T- cell – rich – B – cell
lymphoma by immunohistochemistry. Am J Surg Pathol 1998; 22:1184-1191.
22- Aki H, Tuzune N, Seniz O , et al . T cell rich B cell lymphoma: a clinicopathologic study of 21 cases. Leukemic
Research 2004; 28(3): 229- 236.
23- Browne P, Petrosyan k , Hernandez A, Chan JA.The B cell transcription factors BSAP, Oct -2 and BOB and the pan
B cell markers CD20 , CD 22, and CD79 are useful in the differential diagnosis of classical Hodgkin lymphoma. Am J
Clin Pathol 2003; 120:767-777.
24- Achten R.Nodular lymphocyte predominant Hodgkin’s Lymphoma and T cell histiocyte rich large B cell
lymphoma. Haematol Pathol 2004; 10:385- 393.
25- Vassallo J, lamant L, Brugieres L, Gaillard F, Campo E, Brousset P, et al. ALK positive Anaplastic large cell
lymphoma mimicking Nodular sclerosis Hodgkin’s lymphoma. Am J Surg Pathol 2006; 30:223- 228.
)